Print Page  Close Window


SEC Filings

10-Q
OREXIGEN THERAPEUTICS, INC. filed this Form 10-Q on 05/12/2017
Entire Document
 

 

EXHIBIT INDEX

 

Exhibit
Number

 

 

 

Incorporated by Reference

 

Filed
Herewith

 

Exhibit Description

 

Form

 

File No.

 

Exhibit

 

Filing Date

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.1

 

Amended and Restated Certificate of Incorporation of Orexigen Therapeutics, Inc.

 

S-1

 

333-139496

 

3.2

 

12/19/2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.2

 

Certificate of Amendment of Amended and Restated Certificate of Incorporation of Orexigen Therapeutics, Inc.

 

S-8

 

333-175071

 

3.2

 

06/22/2011

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.3

 

Amended and Restated Bylaws of Orexigen Therapeutics, Inc.

 

S-1

 

333-139496

 

3.4

 

12/19/2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.4

 

Amendment to Amended and Restated Bylaws of Orexigen Therapeutics, Inc.

 

8-K

 

001-33415

 

3.1

 

07/03/2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.5

 

Certificate of Designations, Preferences and Rights of Series Z Non-Convertible Non-Voting Preferred Stock

 

8-K

 

001-33415

 

3.1

 

03/25/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.6

 

Certificate of Amendment of Amended and Restated Certificate of Incorporation of Orexigen Therapeutics, Inc.

 

8-K

 

001-33415

 

3.1

 

07/11/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Form of Common Stock Certificate

 

 

S-1

 

333-139496

 

4.1

 

12/19/2006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Form of Warrant to Purchase Common Stock

 

 

8-K

 

001-33415

 

4.1

 

12/15/2011

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.2

 

Indenture dated as of December 6, 2013, by and between Orexigen Therapeutics, Inc. and Wilmington Trust, National Association, as trustee

 

8-K

 

001-33415

 

4.1

 

09/23/2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.3

 

Form of Warrant to Purchase Common Stock

 

8-K

 

001-33415

 

10.1

 

09/10/2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.4

 

Investor Rights Agreement, dated as of March 15, 2016, by and among Orexigen Therapeutics, Inc., Baupost, and the other investors party thereto

 

8-K

 

001-33415

 

10.2

 

03/25/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.5

 

Securities Purchase Agreement, dated as of March 15, 2016, by and among Orexigen Therapeutics, Inc. and each purchaser party thereto

 

8-K

 

001-33415

 

10.1

 

03/25/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.6

 

Indenture, dated as of March 21, 2016, by and between Orexigen Therapeutics, Inc. and U.S. Bank National Association, as trustee and collateral agent, including the Form of 0% Convertible Senior Secured Note due 2020

 

8-K

 

001-33415

 

4.1

 

03/25/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.7

 

Form of Warrant to Purchase Common Stock

 

8-K

 

001-33415

 

10.4

 

03/15/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.8

 

Supplemental Indenture, dated December 19, 2016, among Orexigen Therapeutics, Inc., U.S. Bank National Association, as trustee and collateral agent, and certain holders of 0% Convertible Senior Secured Notes due 2020

 

8-K

 

001-33415

 

4.1

 

12/19/2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

70